Anti‐Inflammatory Effects of Fermented and Aged Mountain‐Cultivated Ginseng Sprouts via Suppression of MAPK ‐ NF ‐ κB Pathway in Lipopolysaccharide‐Stimulated RAW264 .7 Macrophages
Authors:
Open Access
- 18 October 2024
- journal article
- research article
- Published by Wiley in Food Science & Nutrition
- Vol. 12 (11) , 9566-9576
Abstract
Fermented and aged mountain‐cultivated ginseng sprouts (FAMCGS) exhibit superior antioxidant and anti‐inflammatory properties compared to mountain‐cultivated ginseng sprouts (MCGS). However, the mechanisms behind these properties of FAMCGSE remain unclear. This study explores the anti‐inflammatory effects of FAMCGS extract (FAMCGSE) on LPS‐stimulated RAW 264.7 macrophages and the underlying mechanisms. The MTT assay confirmed that FAMCGSE (0 to 0.1%) maintained cell viability without inducing morphological changes. Pretreatment with FAMCGSE significantly mitigated LPS‐induced morphological alterations dose‐dependently. RT‐PCR and Western blot analyses showed that FAMCGSE significantly reduced the mRNA and protein levels of proinflammatory mediators such as TNF‐α, IL‐1β, IL‐6, iNOS, and COX‐2. Additionally, FAMCGSE decreased the production of TNF‐α, IL‐1β, IL‐6, nitric oxide, and PGE 2 in LPS‐activated RAW264.7 cells. Mechanistically, FAMCGSE inhibited the phosphorylation of mitogen‐activated protein kinases (MAPKs; ERK, p38, and JNK) and prevented the LPS‐induced nuclear translocation of NF‐κB, with effects comparable to compound K (CK) or dexamethasone. Notably, FAMCGSE was particularly effective in inhibiting ERK and JNK activation, with less impact on p38, suggesting a specific inhibitory action on certain MAPK pathways. These findings highlight FAMCGSE's potential as an inhibitor of MAPK and NF‐κB pathways, indicating that FAMCGSE, including its main component CK, may be a promising therapeutic agent for inflammation‐related conditions.Keywords
Funding Information
- National Research Foundation of Korea (#2021R1I1A3044128)
- National Research Foundation of Korea (#RS‐2023‐00219399)
This publication has 39 references indexed in Scilit:
- Changes in nutritional compositions of processed mountain-cultivated ginseng sprouts (Panax ginseng) and screening for their antioxidant and anti-inflammatory propertiesJournal of Functional Foods, 2021
- Pharmacological potential of ginseng and its major component ginsenosidesJournal of Ginseng Research, 2021
- Endophytic Trichoderma citrinoviride isolated from mountain-cultivated ginseng (Panax ginseng) has great potential as a biocontrol agent against ginseng pathogensJournal of Ginseng Research, 2019
- Compound K, a ginsenoside metabolite, plays an antiinflammatory role in macrophages by targeting the AKT1-mediated signaling pathwayJournal of Ginseng Research, 2019
- Ginsenoside compound K protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury via inhibition of nuclear factor-κB, p38, and JNK MAPK pathwaysJournal of Ginseng Research, 2019
- Ginsenoside metabolite compound K exerts anti-inflammatory and analgesic effects via downregulating COX2Inflammopharmacology, 2018
- Role of ginsenosides, the main active components of Panax ginseng , in inflammatory responses and diseasesJournal of Ginseng Research, 2017
- Changes in the ginsenoside content during the fermentation process using microbial strainsJournal of Ginseng Research, 2015
- Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cellsFood and Chemical Toxicology, 2014
- Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophagesInternational Immunopharmacology, 2012